Global COPD and Asthma Devices Market Industry Analysis 2015-2019 with Consort Medical, Gerresheimer, Nypro, Philips Healthcare & RPC Bramlage Dominating

Nov 13, 2015, 12:10 ET from Research and Markets

DUBLIN, Nov. 13, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Global COPD and Asthma Devices Market - Industry Analysis 2015-2019" report to their offering.

The global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019.

The report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.

Vendors are expanding online marketing and promotional activities to provide better accessibility of their products to customers and increase product sales. This strategy also allows vendors to minimize sales mediators, distribution, and reduce operational costs. Many small, medium, and large vendors sell inhalers and nebulizers and their accessories online, proving to be a convenience for consumers. Some of the vendors also provide discounts and promotional offers online, which has increased the overall online purchase. The products offered online also come with a warranty or guarantee from the manufacturer.

According to the report, the rising incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis increases the demand for aerosol drug delivery devices. Exposure to allergens, smoking, and infections in the respiratory tract could cause the lungs to fill with mucus, leading to breathing difficulties. Using aerosol-based mechanism allows the drugs to reach the lungs immediately, helping the person breathe. We also expect the growing use of home medical devices to propel market growth. Home healthcare devices are reliable, comfortable, and easy to use.

Further, the report states that stringent government regulations regarding the safety, quality, and efficacy of COPD and asthma devices hinder market growth. The devices have to comply with numerous standards to enter the market. Obtaining approval is both a lengthy and costly process.

To calculate the market size, the report considers revenue generated from the sales of following COPD and asthma devices:

  • Inhalers
  • Nebulizers

Key vendors

  • Consort Medical
  • Gerresheimer
  • Nypro
  • Philips Healthcare
  • RPC Bramlage

Other prominent vendors

  • Aerogen
  • Airon
  • Allied Healthcare
  • AstraZeneca
  • Boehringer Ingelheim
  • Briggs Healthcare
  • Cardinal Health
  • Clement Clarke International
  • DeVilbiss Healthcare
  • Drive Medical
  • GlaxoSmithKline
  • Heyer Medical
  • Invacare
  • Omron Healthcare
  • PARI Medical
  • Salter Labs
  • Smart Inhaler
  • Sunovion Pharmaceuticals
  • Teleflex
  • Vortran Medical

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets